A detailed history of Arrowstreet Capital, Limited Partnership transactions in Mannkind Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 456,232 shares of MNKD stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
456,232
Holding current value
$2.38 Million
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $1.48 Million - $2.4 Million
456,232 New
456,232 $2.07 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $2.26 Million - $3.15 Million
578,105 New
578,105 $2.39 Million
Q1 2021

May 14, 2021

SELL
$3.14 - $6.14 $374,602 - $732,502
-119,300 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$1.79 - $4.04 $213,547 - $481,972
119,300 New
119,300 $373,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.34B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.